Study pinpoints how a network of different proteins controls rest and activation
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When ...
Tag: Cancer Immunotherapy
Exploring the potential of MSCs in cancer therapy
A new review was published in Oncotarget's Volume 15 on November 22, 2024, entitled "Mesenchymal stem cells – the secret agents of cancer ...
Combination therapy shows promising results in treating stage 3 melanoma
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of ...
Distinct waves of T cells generated by each dose of combination immunotherapy
A new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor therapies works ...
EZH2's role in cancer progression and therapy explored
Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial ...
Targeting epigenetic enzymes in dendritic cells to improve cancer immunotherapy
Immunotherapy is one of the pillars in the fight against cancer and aims to enable the body's own immune system ...
Gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy
Roughly one in five cancer patients benefits from immunotherapy – a treatment that harnesses the immune system to fight cancer. ...
NK cells' role in cancer therapy resistance unveiled
Activated T cells that carry a certain marker protein on their surface are controlled by natural killer (NK) cells, another ...
COST Action bridges the gap in cancer immunotherapy research
Cancer is still a leading cause of death worldwide. Globally, there were an estimated 20 million new cases of cancer ...
St. Jude scientists discover potential CAR T cell therapy target for brain and solid tumors
Findings from St. Jude Children's Research Hospital are moving the field of cancer immunotherapy one step closer to treating brain ...
